GLYCOME BIOPHARMA LIMITED

Glycome BioPharma Limited is a pioneering life‑science company dedicated to advancing safe injectable drug delivery. By developing a next‑generation technology that transforms how biologic medicines are administered, Glycome aims to make cutting‑edge therapies more accessible and easier for patients to use.

The company’s core focus is on creating ready‑to‑use packaging formats that enable self‑medication, boost adherence to treatment regimens and cut hospitalisation costs. This innovative approach addresses the current limitation of biologics—being almost exclusively delivered via injection and confined to specialised drug‑delivery devices—by offering a streamlined, patient‑friendly solution.

Glycome BioPharma’s mission, “advancing safe injectable drug delivery to enable healthier lives,” reflects its commitment to improving outcomes across a range of therapeutic areas where biologics have already revolutionised care. By marrying scientific rigour with practical design, the firm serves patients, healthcare providers and the broader pharmaceutical industry, helping to turn complex biologic treatments into simple, reliable everyday medicines.